Neuroscience

Researchers discover how the brain 're-wires' after disease

Trinity researchers are studying how the brain re-wires itself in neurological disease. The team is building treatments for today's more common global conditions like motor neurone disease (MND/ALS) and spinal muscular ...

Genetics

Concern following gene therapy adverse events

The Editor-in-Chief of Human Gene Therapy, the first journal devoted to the field of gene therapy, and one of the world's leading experts on gene therapy have co-authored a new editorial, Moving Forward After Two Deaths in ...

Genetics

Scientists discover link between ALS genes

The enzyme Gemin3 was identified as the molecular 'bridge' between genes whose mutation or disruption causes amyotrophic lateral sclerosis (ALS), according to a new study in Nature's Scientific Reports from scientists at ...

Medications

Novartis eyes give-away of costly therapy for babies

Swiss pharmaceutical company Novartis is preparing to give away 100 doses of the world's most expensive drug, which treats a rare childhood disorder, but its recipient selection process has drawn criticism.

Diseases, Conditions, Syndromes

High-tech method for uniquely targeted gene therapy

Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe ...

Diseases, Conditions, Syndromes

Study could aid degenerative disease therapies

Fresh insights into how nerves connect with muscles in the body could aid the development of therapies to treat neurodegenerative diseases.

page 1 from 14